How this instrument works
Four body regions, four severity signs apiece. For each region — head and neck, trunk, upper limbs, lower limbs — a clinician rates erythema (redness), induration or papulation (thickness and bumps), excoriation (scratch marks), and lichenification (leathery thickened skin from chronic rubbing), each on a 0-to-3 scale, then adds the four together. That sum is multiplied by an area score, 0 to 6, standing in for the percentage of that region's skin affected, and then by a fixed regional multiplier: 0.1 for head/neck, 0.3 for trunk, 0.2 for upper limbs, 0.4 for lower limbs.
Those four multipliers aren't arbitrary weighting choices; they approximate each region's share of total body surface area under the classic rule of nines used across dermatology and burn assessment. Legs carry roughly four times the surface area of the head and neck, so the lower-limb multiplier, 0.4, sits four times higher than the head/neck multiplier, 0.1 — identical severity signs and area on the legs contribute proportionally more to overall disease burden than the same numbers confined to a small patch of neck. Trunk (0.3) and upper limbs (0.2) fall in between for the same reason.
EASI was adapted from the Psoriasis Area and Severity Index for atopic dermatitis and formally tested for reliability by Hanifin, Thurston, and colleagues in a 2001 study, with 15 evaluators rating 20 patients on consecutive days. It held up well enough on that reliability testing to become a standard outcome measure in eczema drug trials. What it doesn't capture is the patient's own experience — itch, sleep loss, and daily-life impact sit outside its four visible signs entirely, which is why trials often pair it with a separate patient-reported measure rather than relying on this tool alone.
- For each of the four regions, score erythema, induration/papulation, excoriation, and lichenification from 0 (none) to 3 (severe).
- Set that region's area affected on its own 0-6 scale, where 0 is clear skin and 6 covers 90-100% of the region.
- Repeat for all four regions — head/neck, trunk, upper limbs, lower limbs.
- Read each region score individually, or the EASI total (0-72) that sums all four.
Worked example — moderate eczema across all four regions
Head/neck: erythema 2, induration 2, excoriation 1, lichenification 1 sum to 6; area affected is 3. Region score: 6 × 3 × 0.1 = 1.8. Trunk: erythema 1, induration 1, excoriation 0, lichenification 1 sum to 3; area 2. Region score: 3 × 2 × 0.3 = 1.8.
Upper limbs: signs sum to 7 (2+2+2+1); area 4. Region score: 7 × 4 × 0.2 = 5.6. Lower limbs: signs sum to 5 (1+1+1+2); area 3. Region score: 5 × 3 × 0.4 = 6.0. Total EASI: 1.8 + 1.8 + 5.6 + 6.0 = 15.2 — moderate disease by commonly used interpretive bands, where 7.1 to 21 is moderate.
Questions
Why does the same eczema severity score so differently on the legs versus the head and neck?
Because the regional multipliers aren't measuring severity twice — they're standing in for how much skin each region actually covers. Under the rule of nines used across dermatology and burn assessment, the legs represent roughly four times the surface area of the head and neck, so the lower-limb multiplier (0.4) is set four times higher than the head/neck multiplier (0.1). Identical severity signs and identical area scores on the legs therefore add more to the total than the same numbers would on the neck, because more actual skin is involved.
What do the four severity signs actually measure?
Erythema is redness, induration/papulation is the raised, thickened quality of active lesions, excoriation is visible scratch damage, and lichenification is the leathery, thickened skin that develops from long-term rubbing and scratching. Each is rated 0 (absent) to 3 (severe) by the person examining the skin, and the four ratings for a region are simply added together before area and multiplier are applied.
How is the area-affected score assigned?
Each region gets its own 0-to-6 rating standing in for the percentage of that region's skin involved: 0 for none, up through 6 for 90-100%. It's assessed separately for each of the four regions, so a person could have extensive area on the trunk and minimal area on the arms within the same evaluation, and the two wouldn't average out — each region keeps its own number.
What EASI score counts as mild, moderate, or severe disease?
A commonly used interpretive scale from a 2015 study puts 0 at clear, 0.1 to 1.0 as almost clear, 1.1 to 7.0 as mild, 7.1 to 21.0 as moderate, 21.1 to 50.0 as severe, and 50.1 to 72.0 as very severe. These bands are a research convention for grouping trial participants, not a formal diagnostic cutoff — a clinician interprets a given score in the context of how a specific case is behaving.
Does a higher EASI score always mean someone is more uncomfortable?
Not necessarily. This tool scores only the four visible signs on the skin itself — it says nothing about itch, sleep disruption, or how much the disease affects daily life, which is why researchers often pair it with a separate patient-reported symptom measure. Two people with the same total can report very different levels of discomfort.
Is EASI used to diagnose eczema?
No. It assumes a diagnosis of atopic dermatitis has already been made by a clinician using recognized diagnostic criteria, then tracks how severe and extensive that existing diagnosis is over time, commonly before and after starting treatment. It isn't built to distinguish eczema from other rashes in the first place.
References
- Hanifin JM, Thurston M, Omoto M, et al., EASI Evaluator Group, 2001, Exp Dermatol — original reliability study (PubMed)
- Leshem YA, Hajar T, Hanifin JM, Simpson EL, 2015, Br J Dermatol — EASI interpretability study (PubMed)
Read this first: This instrument computes a screening figure from population formulas — it is not a diagnosis, and it cannot see the whole picture a clinician can. Use it to inform a conversation, not to replace one.